Business & Consumer Services » General Services | Eagle Legend Asia Ltd.

Eagle Legend Asia Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
290,972.00
305,278.00
239,755.00
156,160.00
206,805.00
190,316
Cost of Goods Sold (COGS) incl. D&A
155,717.00
166,939.00
145,375.00
83,738.00
98,782.00
141,092
Gross Income
135,255.00
138,339.00
94,380.00
72,422.00
108,023.00
49,224
SG&A Expense
64,379.00
81,110.00
68,593.00
66,096.00
62,317.00
77,226
EBIT
25,438.00
57,777.00
25,788.00
-
45,706.00
28,002
Unusual Expense
3,280.00
665.00
453.00
-
55,111.00
85,601
Non Operating Income/Expense
11,282.00
43,488.00
42,818.00
47,597.00
62,476.00
12,287
Interest Expense
22,987.00
26,881.00
26,478.00
25,642.00
49,827.00
37,766
Pretax Income
11,496.00
10,958.00
43,402.00
66,861.00
9,926.00
9,806
Income Tax
2,559.00
225.00
1,333.00
2,599.00
1,924.00
1,833
Consolidated Net Income
8,937.00
11,183.00
42,069.00
64,262.00
8,002.00
11,639
Net Income
9,254.00
11,079.00
42,035.00
64,255.00
47,768.00
42,672
Net Income After Extraordinaries
9,254.00
11,079.00
42,035.00
56,367.00
48,087.00
42,672
Net Income Available to Common
9,254.00
11,079.00
42,035.00
72,143.00
48,680.00
42,672
EPS (Basic)
0.01
0.01
0.05
0.08
0.05
0.04
Basic Shares Outstanding
800,000.00
800,000.00
800,000.00
874,316.90
970,684.90
1,060,000
EPS (Diluted)
0.01
0.01
0.05
0.08
0.05
0.04
Diluted Shares Outstanding
800,000.00
800,000.00
800,000.00
874,316.90
970,684.90
1,060,000
EBITDA
71,429.00
108,006.00
71,888.00
47,149.00
100,551.00
27,416
Other Operating Expense
45,438.00
548.00
1.00
-
-
-
Non-Operating Interest Income
1,043.00
2,299.00
559.00
52.00
183.00
1,112
Minority Interest Expense
317.00
104.00
34.00
7.00
39,766.00
54,311

About Eagle Legend Asia

View Profile
Address
Room 3607, 36/F
Hong Kong
Hong Kong
Employees -
Website http://www.elasialtd.com
Updated 07/08/2019
Eagle Legend Asia Ltd. operates as an investment holding company, engages in the trading of construction machinery and spare parts. Its activities also include the manufacture and sale of proprietary Chinese medicines and health products; and the cultivation, research, processing, and sale of exocarpium citri grandis and its seedlings. It operates through the following geographical segments: Hong Kong, Singapore, Vietnam, Macau, and People's Republic of China segments.